ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,118.25
1.07%
Dow Jones
38,642.75
1.09%
US Dollar vs MXN
17.01285
0.24%
Brent Oil
83.315
-0.38%
Bitcoin
61,590.61
4.18%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Alpha Tau Medical Ltd (DRTS)

  7. Alpha Tau Medical Ltd (DRTS) Noticias

DRTS Alpha Tau Medical Ltd

2.39
0.04 (1.70%)
Última actualización: 10:04:36
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Alpha Tau Medical Ltd DRTS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.04 1.70% 2.39 10:04:36
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.43 2.39 2.43 2.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:30GLOBEAlpha Tau to Participate in May Investor Conferences
25/3/202407:50GLOBEAlpha Tau to Present at the Jefferies Radiopharma Innovation..
07/3/202415:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202415:01GLOBEAlpha Tau Medical Announces Full Year 2023 Financial Results..
26/2/202407:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202407:30GLOBEAlpha Tau to Participate in Barclays 26th Annual Global..
20/12/202308:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202308:15GLOBEAlpha Tau to Present at the 42nd Annual J.P. Morgan..
18/12/202310:09EDGAR2Form 144 - Report of proposed sale of securities
29/11/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202307:30GLOBEAlpha Tau to Participate in Sidoti Small-Cap Conference
28/11/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202307:30GLOBEAlpha Tau Announces Highly Promising Interim Results from..
21/11/202305:18EDGAR2Form 144 - Report of proposed sale of securities
20/11/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202307:30GLOBEAlpha Tau Submits to Japanese PMDA for Pre-Market Approval..
16/11/202315:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202315:30GLOBEAlpha Tau Medical Announces Third Quarter 2023 Financial..
01/11/202316:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202307:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202307:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202307:30GLOBEAlpha Tau Enters Into Long-Term Lease of Site in New..
24/10/202308:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202308:00GLOBEFormer U.S. Commissioner of Food and Drug Administration..
27/9/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
14/9/202307:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/9/202307:30GLOBEAlpha Tau Treats First Patient with Advanced Inoperable..
11/9/202315:16EDGAR2Form F-3 - Registration statement by foreign private issuers
28/8/202315:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202315:02GLOBEAlpha Tau Medical Announces Second Quarter 2023 Financial..
24/8/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202316:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202316:00GLOBEAlpha Tau Announces Robust Long-Term Safety and Efficacy..
02/8/202308:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202315:01GLOBEAlpha Tau Medical to Participate in June Investor..
23/5/202315:01GLOBEAlpha Tau Medical Announces First Quarter 2023 Financial..
17/5/202315:30GLOBEAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer..
11/5/202315:00GLOBEAlpha Tau Announces the Publication of its US Multicenter..

Su Consulta Reciente

NASDAQ
DRTS
Alpha Tau Medical
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados